Literature DB >> 3363867

Isolation and characterization of monoclonal antibodies against the adenovirus core proteins.

R Lunt1, M E Vayda, M Young, S J Flint.   

Abstract

Monoclonal antibodies have been prepared that recognize adenovirus core proteins V, VII, and mu in ELISA and Western blot assays. Antibodies produced by all of 87 positive hybridoma colonies obtained from a mouse injected with the precursor to protein VII, pVII, produced antibodies that also reacted with purified protein VII in an ELISA assay and all tested recognized denatured protein VII immobilized on nitrocellulose. Such failure to recover antibodies that specifically recognized only protein pVII suggests that epitopes common to the 174 amino acid protein VII and its 197 amino acid precursor were more effective antigenic determinants than the N-terminal 23 amino acid segment unique to pVII. All antibodies raised against protein mu cross-reacted with protein VII in both assays, but only a small fraction of the anti-protein VII or pVII antibodies recognized protein mu. Such cross-reactivity is discussed in relation to an unusual, arginine-rich sequence present in both protein VII and protein mu.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3363867     DOI: 10.1016/0042-6822(88)90645-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

1.  Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts.

Authors:  Ramon Gonzalez; Wenying Huang; Renee Finnen; Courtney Bragg; S J Flint
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Authors:  N Winter; J C D'Halluin
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Processing of the l1 52/55k protein by the adenovirus protease: a new substrate and new insights into virion maturation.

Authors:  Ana J Pérez-Berná; Walter F Mangel; William J McGrath; Vito Graziano; Jane Flint; Carmen San Martín
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

4.  Structures of Adenovirus Incomplete Particles Clarify Capsid Architecture and Show Maturation Changes of Packaging Protein L1 52/55k.

Authors:  Gabriela N Condezo; Roberto Marabini; Silvia Ayora; José M Carazo; Raúl Alba; Miguel Chillón; Carmen San Martín
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

5.  The repression domain of the E1B 55-kilodalton protein participates in countering interferon-induced inhibition of adenovirus replication.

Authors:  Jasdave S Chahal; Courtney Gallagher; Caroline J DeHart; S J Flint
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

Review 6.  Novel molecular approaches to cystic fibrosis gene therapy.

Authors:  Tim W R Lee; David A Matthews; G Eric Blair
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

7.  Export of adenoviral late mRNA from the nucleus requires the Nxf1/Tap export receptor.

Authors:  Gayatri Yatherajam; Wenying Huang; S J Flint
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

8.  Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.

Authors:  George Hung; S J Flint
Journal:  Virology       Date:  2017-01-27       Impact factor: 3.616

9.  Role of the RNA recognition motif of the E1B 55 kDa protein in the adenovirus type 5 infectious cycle.

Authors:  Sayuri E M Kato; Wenying Huang; S J Flint
Journal:  Virology       Date:  2011-05-24       Impact factor: 3.616

10.  Reduced infectivity of adenovirus type 5 particles and degradation of entering viral genomes associated with incomplete processing of the preterminal protein.

Authors:  Sayuri E Kato; Jasdave S Chahal; S J Flint
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.